達(da)安基因7月20日(ri)公(gong)(gong)(gong)(gong)告(gao)，公(gong)(gong)(gong)(gong)司(si)(si)(si)及公(gong)(gong)(gong)(gong)司(si)(si)(si)全資子(zi)(zi)公(gong)(gong)(gong)(gong)司(si)(si)(si)廣州市達(da)安基因科(ke)(ke)技有限公(gong)(gong)(gong)(gong)司(si)(si)(si)近日(ri)分(fen)別收(shou)到參股公(gong)(gong)(gong)(gong)司(si)(si)(si)杭州安杰(jie)思(si)醫學科(ke)(ke)技股份有限公(gong)(gong)(gong)(gong)司(si)(si)(si)的現(xian)金分(fen)紅(hong)(hong)款，公(gong)(gong)(gong)(gong)司(si)(si)(si)對安杰(jie)思(si)持(chi)股比(bi)例(li)約為10.37%，本次分(fen)紅(hong)(hong)金額為456萬(wan)元(yuan)。公(gong)(gong)(gong)(gong)司(si)(si)(si)全資子(zi)(zi)公(gong)(gong)(gong)(gong)司(si)(si)(si)達(da)安科(ke)(ke)技對安杰(jie)思(si)持(chi)股比(bi)例(li)約為4.47%，本次分(fen)紅(hong)(hong)金額為196.81萬(wan)元(yuan)。近日(ri)，公(gong)(gong)(gong)(gong)司(si)(si)(si)已收(shou)到上述分(fen)紅(hong)(hong)款456萬(wan)元(yuan)，公(gong)(gong)(gong)(gong)司(si)(si)(si)全資子(zi)(zi)公(gong)(gong)(gong)(gong)司(si)(si)(si)達(da)安科(ke)(ke)技已收(shou)到上述分(fen)紅(hong)(hong)款196.81萬(wan)元(yuan)。上述利潤(run)分(fen)配將增加公(gong)(gong)(gong)(gong)司(si)(si)(si)2023年度合并報表凈利潤(run)652.81萬(wan)元(yuan)。